Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:investor
|
| gptkbp:focusesOn |
gptkb:biotechnology
gptkb:insurance Life sciences |
| gptkbp:foundedIn |
2008
|
| gptkbp:headquartersLocation |
gptkb:China
gptkb:Shanghai |
| gptkbp:industry |
Venture capital
|
| gptkbp:investedIn |
Early-stage companies
Growth-stage companies |
| gptkbp:managingPartner |
gptkb:Yi_Shi
|
| gptkbp:notableInvestment |
gptkb:CANbridge_Pharmaceuticals
gptkb:Zai_Lab gptkb:Innovent_Biologics gptkb:JW_Therapeutics |
| gptkbp:originatedIn |
gptkb:Eli_Lilly_and_Company
|
| gptkbp:regionServed |
gptkb:Asia
gptkb:Europe gptkb:United_States |
| gptkbp:website |
https://www.lillyasiaventures.com/
|
| gptkbp:bfsParent |
gptkb:Eikon_Therapeutics
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lilly Asia Ventures
|